Skip to main content
. 2017 Mar 2;7:43711. doi: 10.1038/srep43711

Figure 5. Infectivity of PF-46396-resistant mutants.

Figure 5

TZM-bl cells were infected with p24 normalized K3016 WT or mutant virus that has been either PF-46396 (5.0 μM) treated or DMSO-treated. The cells were lysed after 48 h post infection and assayed for luciferase activity. Quantitative data for levels of infectivity relative to DMSO control-treated sample are shown (n = 3). Error bars indicate standard deviations.